FDA Issues Guidance on Blood Lancet Labeling to Address Adverse Health Risks

Summary

The FDA is releasing a new guidance document to inform healthcare providers and patients about the risks associated with using the same blood lancet device for multiple patients and is requiring all devices to be labeled for single-patient use.